Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Nutr Metab (Lond) ; 9(1): 76, 2012 Aug 21.
Artigo em Inglês | MEDLINE | ID: mdl-22909172

RESUMO

BACKGROUND AND AIMS: The aim of the present investigation was to examine the anti-wasting effects of theophylline (a methylxantine present in tea leaves) on a rat model of cancer cachexia. METHODS: The in vitro effects of the nutraceuticals on proteolysis were examined on muscle cell cultures submitted to hyperthermia. Individual muscle weights, muscle gene expression, body composition and cardiac function were measured in rats bearing the Yoshida AH-130 ascites hepatoma, following theophylline treatment. RESULTS: Theophylline treatment inhibited proteolysis in C2C12 cell line and resulted in an anti-proteolytic effect on muscle tissue (soleus and heart), which was associated with a decrease in circulating TNF-alpha levels and with a decreased proteolytic systems gene expression. Treatment with the nutraceutical also resulted in an improvement in body composition and cardiac function. CONCLUSION: Theophylline - alone or in combination with drugs - may be a candidate molecule for the treatment of cancer cachexia.

2.
Clin Nutr ; 30(1): 33-7, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20655130

RESUMO

BACKGROUND & AIMS: The abnormalities associated with cancer cachexia include anorexia, weight loss, muscle loss and atrophy, anaemia and alterations in carbohydrate, lipid and protein metabolism. The aim of the present investigation was to examine the anti-wasting effects of some nutraceuticals such as genistein, resveratrol, epigallocatechin gallate and diallyl sulphide (DAS). METHODS: The in vitro effects of these nutraceuticals on proteolysis were examined in muscle cell cultures submitted to hyperthermia. The in vivo effects of DAS were also tested in cachectic tumour-bearing rats (Yoshida AH-130 ascites hepatoma). RESULTS: Although all the nutraceuticals tested inhibited muscle proteolysis, the most promising effects were related with DAS. In vivo administration of DAS only leads to a small improvement in tibialis muscle and heart weights; however, administration of DAS to healthy animals increased all muscle weights, this being associated with a decreased gene expression of proteolytic systems components. CONCLUSION: It may be suggested that DAS could be used to improve muscle mass during healthy conditions.


Assuntos
Compostos Alílicos/administração & dosagem , Caquexia/tratamento farmacológico , Suplementos Nutricionais , Músculo Esquelético/metabolismo , Sulfetos/administração & dosagem , Animais , Anorexia/complicações , Anorexia/tratamento farmacológico , Caquexia/complicações , Catequina/análogos & derivados , Catequina/farmacologia , Células Cultivadas , Genisteína/farmacologia , Masculino , Atrofia Muscular/complicações , Neoplasias/complicações , Neoplasias/tratamento farmacológico , Ratos , Ratos Wistar , Resveratrol , Estilbenos/farmacologia , Redução de Peso
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...